Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Camrelizumab and Microwave Ablation in Early-Stage Breast Cancer
NCT04805736Phase 2Completed
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Mar 2021
- Primary completion
- Apr 2023
- Modality
- Immune Checkpoint Inhibitors
- Countries
- 1
01
Overview
A Phase 2 trial of camrelizumab in breast cancer, sponsored by Jiangsu Provincial People's Hospital. Started Mar 2021; status: completed.
02
Drugs
camrelizumab
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04805736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04805736.